{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:27:16Z","timestamp":1784237236250,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jclinane.2023.111271","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T21:34:42Z","timestamp":1696887282000},"page":"111271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Perioperative implications of amyloidosis and amyloid cardiomyopathy: A review for anesthesiologists"],"prefix":"10.1016","volume":"92","author":[{"given":"Michael A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil G.","family":"Feinglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11912-021-01028-8","article-title":"Updates in cardiac amyloidosis diagnosis and treatment","volume":"23","author":"Stern","year":"2021","journal-title":"Curr Oncol Rep"},{"issue":"22","key":"10.1016\/j.jclinane.2023.111271_bb0010","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jclinane.2023.111271_bb0015","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.jclinane.2023.111271_bb0020","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation."},{"issue":"12","key":"10.1016\/j.jclinane.2023.111271_bb0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0030","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/diagnostics12030627","article-title":"Multimodal imaging and biomarkers in cardiac amyloidosis","volume":"12","author":"Jung","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13506129.2018.1436048","article-title":"Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)","volume":"25","author":"Phull","year":"2018","journal-title":"Amyloid."},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.hfc.2022.02.005","article-title":"Cardiac amyloidosis","volume":"18","author":"Gertz","year":"2022","journal-title":"Heart Fail Clin"},{"issue":"5","key":"10.1016\/j.jclinane.2023.111271_bb0045","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jclinane.2023.111271_bb0060","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0065","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid."},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13506129.2018.1519507","article-title":"Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center\u2019s experience","volume":"25","author":"Ikram","year":"2018","journal-title":"Amyloid."},{"issue":"8","key":"10.1016\/j.jclinane.2023.111271_bb0075","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2005-07-2922","article-title":"Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"107","author":"Dispenzieri","year":"2006","journal-title":"Blood."},{"issue":"10","key":"10.1016\/j.jclinane.2023.111271_bb0080","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1182\/blood-2005-11-4385","article-title":"Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL","volume":"107","author":"Palladini","year":"2006","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.6004\/jnccn.2022.7092","article-title":"Individualized approach to management of light chain amyloidosis","volume":"21","author":"Palladini","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.jclinane.2023.111271_bb0090","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/tri.13326","article-title":"Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study","volume":"31","author":"Vollmar","year":"2018","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.echo.2013.12.010","article-title":"Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy","volume":"27","author":"Suresh","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jchf.2019.12.013","article-title":"Outcomes in patients with cardiac amyloidosis undergoing heart transplantation","volume":"8","author":"Barrett","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.transproceed.2020.08.020","article-title":"Outcomes of heart transplantation in cardiac amyloidosis patients: a single center experience","volume":"53","author":"Chen","year":"2021","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"issue":"Suppl. 2","key":"10.1016\/j.jclinane.2023.111271_bb0115","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med (Lond)"},{"issue":"11","key":"10.1016\/j.jclinane.2023.111271_bb0120","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine OF","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.mayocp.2018.08.041","article-title":"Incidence of AL amyloidosis in Olmsted County, Minnesota, 1990 through 2015","volume":"94","author":"Kyle","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.jclinane.2023.111271_bb0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jclinane.2023.111271_bb0140","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jclinane.2023.111271_bb0145","doi-asserted-by":"crossref","first-page":"E2403","DOI":"10.1002\/humu.22619","article-title":"Online registry for mutations in hereditary amyloidosis including nomenclature recommendations","volume":"35","author":"Rowczenio","year":"2014","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14,333 African-Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid."},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jnnp.59.1.45","article-title":"Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study","volume":"59","author":"Reilly","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.jclinane.2023.111271_bb0160","doi-asserted-by":"crossref","first-page":"P22","DOI":"10.1186\/1750-1172-10-S1-P22","article-title":"Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium","volume":"10","author":"Lousada","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","article-title":"Light Chain (AL) amyloidosis: the journey to diagnosis","volume":"11","author":"McCausland","year":"2018","journal-title":"Patient."},{"issue":"14","key":"10.1016\/j.jclinane.2023.111271_bb0175","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart."},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.55519\/JAMC-01-9317","article-title":"Macroglossia associated with primary systemic amyloidosis - case report with unusual clinical presentation","volume":"34","author":"Muniyan","year":"2022","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"10.1016\/j.jclinane.2023.111271_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11897-020-00457-z","article-title":"Disease-specific biomarkers in transthyretin cardiac amyloidosis","volume":"17","author":"Hendren","year":"2020","journal-title":"Curr Heart Fail Rep"},{"issue":"18","key":"10.1016\/j.jclinane.2023.111271_bb0195","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bjh.15955","article-title":"Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers","volume":"186","author":"Rezk","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jclinane.2023.111271_bb0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2020.01.002","article-title":"Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter","volume":"222","author":"Loungani","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jclinane.2023.111271_bb0215","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijcard.2016.07.254","article-title":"Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis","volume":"222","author":"Hamon","year":"2016","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.jclinane.2023.111271_bb0220","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13506120600876849","article-title":"Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy","volume":"13","author":"Suhr","year":"2006","journal-title":"Amyloid."},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcmg.2007.12.007","article-title":"Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range","volume":"2","author":"Marwick","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.jclinane.2023.111271_bb0240","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart."},{"issue":"11","key":"10.1016\/j.jclinane.2023.111271_bb0245","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jcmg.2015.11.013","article-title":"The relation of ejection fraction and global longitudinal strain in amyloidosis: implications for differential diagnosis","volume":"9","author":"Pagourelias","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.jclinane.2023.111271_bb0250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.echo.2022.12.021","article-title":"Ejection fraction basal strain ratio: a new composite echocardiographic deformation parameter allowing differentiation of cardiac amyloidosis from hypertrophic cardiomyopathies","volume":"36","author":"Martel","year":"2023","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9149(97)00293-2","article-title":"Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy","volume":"80","author":"Gertz","year":"1997","journal-title":"Am J Cardiol"},{"issue":"38","key":"10.1016\/j.jclinane.2023.111271_bb0270","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0395","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0952-8180(99)00046-X","article-title":"Anesthetic management of a patient with laryngeal amyloidosis","volume":"11","author":"Noguchi","year":"1999","journal-title":"J Clin Anesth"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0410","doi-asserted-by":"crossref","first-page":"E1912","DOI":"10.1002\/lary.29320","article-title":"One hundred cases of localized laryngeal amyloidosis - evidence for future management","volume":"131","author":"Harris","year":"2021","journal-title":"Laryngoscope."},{"issue":"10038","key":"10.1016\/j.jclinane.2023.111271_bb0275","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12891-020-03912-z","article-title":"Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery","volume":"22","author":"Wininger","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"issue":"17","key":"10.1016\/j.jclinane.2023.111271_bb0285","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0290","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a Prospective, Observational Cohort Study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jclinane.2023.111271_bb0295","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"Aus dem Siepen","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"10.1016\/j.jclinane.2023.111271_bb0300","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jhsa.2019.06.016","article-title":"Carpal tunnel syndrome: a potential early, red-flag sign of amyloidosis","volume":"44","author":"Donnelly","year":"2019","journal-title":"J Hand Surg Am"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0305","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03009734.2014.895786","article-title":"Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis","volume":"119","author":"Westermark","year":"2014","journal-title":"Ups J Med Sci"},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0310","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","author":"Yanagisawa","year":"2015","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.jclinane.2023.111271_bb0315","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"JAMA."},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2017.1375908","article-title":"Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?","volume":"24","author":"Rubin","year":"2017","journal-title":"Amyloid."},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0325","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","article-title":"Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis","volume":"104","author":"Pollak","year":"1993","journal-title":"Chest."},{"issue":"9","key":"10.1016\/j.jclinane.2023.111271_bb0330","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/thx.37.9.711","article-title":"Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine","volume":"37","author":"Griffiths","year":"1982","journal-title":"Thorax."},{"issue":"13 Pt 1","key":"10.1016\/j.jclinane.2023.111271_bb0335","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","article-title":"Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0340","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0345","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13506129.2018.1449744","article-title":"Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?","volume":"25","author":"Muchtar","year":"2018","journal-title":"Amyloid."},{"issue":"133","key":"10.1016\/j.jclinane.2023.111271_bb0350","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.amjcard.2020.07.034","article-title":"Digoxin use in cardiac amyloidosis","author":"Donnelly","year":"2020","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.jclinane.2023.111271_bb0355","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"issue":"7\u20138","key":"10.1016\/j.jclinane.2023.111271_bb0360","first-page":"689","article-title":"Haemodynamics during liver transplantation in familial amyloidotic polyneuropathy: study of the intraoperative cardiocirculatory data of 50 patients","volume":"18","author":"Viana Jda","year":"1999","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jclinane.2023.111271_bb0365","series-title":"Basics of anesthesia","author":"Miller","year":"2011"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0370","first-page":"53","article-title":"Anesthetic experience of emergency coronary artery bypass graft operation in a patient with cardioamyloidosis","volume":"50","author":"Fukagawa","year":"2001","journal-title":"Masui"},{"issue":"7","key":"10.1016\/j.jclinane.2023.111271_bb0375","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.transproceed.2007.07.058","article-title":"Anesthetic management of a combined heart and liver transplantation in an amyloidotic patient: a case report","volume":"39","author":"Barrio","year":"2007","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0380","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jclinane.2004.03.014","article-title":"Systemic vasodilation is a predominant cause of hypotension in a patient with familial amyloid polyneuropathy during liver transplantation","volume":"17","author":"Neelakanta","year":"2005","journal-title":"J Clin Anesth"},{"issue":"1","key":"10.1016\/j.jclinane.2023.111271_bb0385","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/0259-1162.200235","article-title":"Amyloidosis and anesthesia","volume":"11","author":"Wani","year":"2017","journal-title":"Anesth Essays Res"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0390","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1399-6576.1997.tb04778.x","article-title":"Serum potassium concentrations after suxamethonium in patients with familial amyloid polyneuropathy type I","volume":"41","author":"Viana","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jclinane.2023.111271_bb0400","doi-asserted-by":"crossref","unstructured":"Espa\u00f1a Fuente L, Mella P\u00e9rez G, Laserna Cocina B, Gonz\u00e1lez Gonz\u00e1lez JL. Can videolaryngoscopy be a first option in a patient with laryngeal amyloidosis? Rev Esp Anestesiol Reanim (Engl Ed). 2018 Mar; 65(3):160\u2013164. doi: https:\/\/doi.org\/10.1016\/j.redar.2017.06.006. English, Spanish. Epub 2017 Jul 31. PMID: 28774673.","DOI":"10.1016\/j.redare.2018.01.005"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0405","first-page":"453","article-title":"Update for nurse anesthetists\u2013anesthetic considerations for patients with amyloidosis","volume":"73","author":"Nisbit","year":"2005","journal-title":"AANA J"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0415","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1213\/01.ane.0000290304.02125.6e","article-title":"Periorbital ecchymoses during general anesthesia in a patient with primary amyloidosis: a harbinger for bleeding?","volume":"105","author":"Weingarten","year":"2007","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0952-8180(99)00009-4","article-title":"A reaction to tape after tracheal extubation in a patient with systemic amyloidosis","volume":"11","author":"Campos","year":"1999","journal-title":"J Clin Anesth"},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0425","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1399-6576.1986.tb02422.x","article-title":"Cardiac arrhythmias in familial amyloid polyneuropathy during anesthesia","volume":"30","author":"Eriksson","year":"1986","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0430","first-page":"1233","article-title":"Intraoperative death in cardiac amyloidosis with increased QT dispersion in the electrocardiogram","volume":"80","author":"Tallgren","year":"1995","journal-title":"Anesth Analg"},{"issue":"24","key":"10.1016\/j.jclinane.2023.111271_bb0435","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1161\/hc4901.100380","article-title":"Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy","volume":"104","author":"Delahaye","year":"2001","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0440","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0959-289X(98)80052-6","article-title":"Anesthesia for caesarean section in a patient with systemic amyloidosis secondary to familial Mediterranean fever","volume":"7","author":"Weir","year":"1998","journal-title":"Int J Obstet Anesth"},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0445","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.0265-0215.1998.00263.x","article-title":"Management of a patient with familial amyloid polyneuropathy type I with lumbar epidural anesthesia","volume":"15","author":"Shono","year":"1998","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0450","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00000542-200003000-00035","article-title":"Postoperative ventricular fibrillation and undiagnosed primary amyloidosis","volume":"92","author":"Wang","year":"2000","journal-title":"Anesthesiology."},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0455","doi-asserted-by":"crossref","first-page":"327","DOI":"10.6002\/ect.2012.0257","article-title":"Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy","volume":"11","author":"Ohya","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jclinane.2023.111271_bb0460","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-015-0284-4","article-title":"Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis","volume":"15","author":"Wixner","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0465","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7182\/pit2014615","article-title":"A psychosomatic approach to severe nausea and vomiting in liver transplant recipients with familial amyloid polyneuropathy: clinical outcome in 10 cases","volume":"24","author":"Telles-Correia","year":"2014","journal-title":"Prog Transplant"},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0470","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1432-2277.2008.00737.x","article-title":"High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy","volume":"22","author":"Bispo","year":"2009","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.jclinane.2023.111271_bb0475","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","article-title":"A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation","volume":"77","author":"Ando","year":"2004","journal-title":"Transplantation."},{"issue":"5","key":"10.1016\/j.jclinane.2023.111271_bb0480","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/00007890-200203150-00015","article-title":"Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type","volume":"73","author":"Olofsson","year":"2002","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.jclinane.2023.111271_bb0485","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1159\/000082251","article-title":"Long-term evaluation of neuromyopathy in live donor FMF amyloidotic kidney transplant recipients","volume":"24","author":"Sherif","year":"2004","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.jclinane.2023.111271_bb0490","doi-asserted-by":"crossref","first-page":"324","DOI":"10.6002\/ect.2018.0371","article-title":"Long-term outcomes of patients with amyloidosis following kidney transplant","volume":"21","author":"Heybeli","year":"2023","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"10.1016\/j.jclinane.2023.111271_bb0495","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-0012.1998.tb00984.x","article-title":"Transplantation in renal amyloidosis","volume":"12","author":"T\u00fcrkmen","year":"1998","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.jclinane.2023.111271_bb0500","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.transproceed.2006.01.003","article-title":"Outcome of kidney transplantation for renal amyloidosis:a single-center experience","volume":"38","author":"Celik","year":"2006","journal-title":"Transplant Proc"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818023002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818023002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:24:17Z","timestamp":1760606657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818023002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":96,"alternative-id":["S0952818023002210"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2023.111271","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative implications of amyloidosis and amyloid cardiomyopathy: A review for anesthesiologists","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2023.111271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111271"}}